Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.
Lancet Respir Med. 2020 Aug;8(8):807-815. doi: 10.1016/S2213-2600(20)30225-3. Epub 2020 May 15.
Lancet Respir Med. 2020.
PMID: 32422178
Free PMC article.
Review.